Wellington Partners Investment Portfolio and Life Sciences Focus

Wellington Partners has a strong focus on life sciences, with a portfolio that includes companies in the biotechnology and pharmaceutical sectors. They have invested in various companies, including those focused on developing new treatments for diseases.

Their investment portfolio is diverse, with companies operating in different stages of development, from early-stage biotechs to established pharmaceutical companies. This diversity allows them to support a wide range of innovative projects and ideas.

Wellington Partners has a team of experienced investment professionals who work closely with entrepreneurs and researchers to identify and support promising life sciences companies. This collaborative approach has led to successful investments in companies that are making a significant impact in the field.

Wellington Partners is a unique investment firm that prides itself on being "Entrepreneurs for Entrepreneurs". This motto reflects their commitment to supporting ambitious entrepreneurs in Europe.

They've got a wealth of experience, having accompanied and supported over 100 portfolio companies through the ups and downs of their industry over the past 20 years.

Their approach is built on fostering strong relationships between entrepreneurs, which has always been a top priority for them.

Wellington Partners is a team of experienced investors who have been in the entrepreneur's shoes themselves. They take pride in their motto "Entrepreneurs for Entrepreneurs", reflecting their unique perspective as former entrepreneurs.

With over 20 years of experience, they've had the privilege of accompanying and supporting more than 100 portfolio companies through the ups and downs of their industries.

Wellington Partners is a venture capital firm that has been investing in European life science companies for over 20 years. They have a strong track record of success, with over 40 exits and a significant return on investment.

Their investment team is comprised of experienced professionals who have a deep understanding of the life science industry. They have a keen eye for spotting innovative technologies and companies with strong growth potential.

The firm's investment focus is on early-stage companies that have a clear commercial strategy and a strong management team. They look for companies that are developing innovative products and technologies that have the potential to make a significant impact in the life science industry.

Wellington Partners has a strong track record of investing in promising startups. They've raised and invested five generations of VC funds with a total volume of € 700 million.

Their focus is now on value creation, working closely with their existing portfolio companies. They're committed to providing the resources needed to help entrepreneurs succeed.

The team proactively sources deals and leads or co-leads financing rounds, typically ranging from €1 million to €10 million or higher.